返回 Agenda
Session 5: Program Safety Analysis Plan
Session Chair(s)
James Buchanan, PHARMD
President
Covilance LLC, United States
- SPERT recommendations
- Tier 1: Pre-specified hypotheses
- Tier 2: Signal detection among common events
- Tier 3: Descriptive analysis of infrequent events